Profil
Actuellement, Al Boyle occupe le poste de directeur des opérations techniques et de la qualité chez Alnylam Pharmaceuticals, Inc. Auparavant, M. Boyle était vice-président des services techniques mondiaux chez Alexion Pharmaceuticals, Inc. Al Boyle a obtenu un diplôme de premier cycle et un diplôme d'études supérieures du SUNY College of Environmental Science et un doctorat de la Rutgers State University of New Jersey.
Anciens postes connus de Al Boyle
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2015 |
Formation de Al Boyle
| SUNY College of Environmental Science | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
